Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft technology platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers translational oncology solutions that utilizes its technology platform to provide research services that assist in the drug development process of pharmaceutical and biotechnology companies. In addition, the company offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. It markets its products through internet and sales force to pharmaceutical and biotechnology companies. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey. Show more

Location: One University Plaza, Hackensack, NJ, 07601, United States | Website: https://www.championsoncology.com | Industry: Biotechnology | Sector: Healthcare


Market Cap

87.9M

52 Wk Range

$3.60 - $11.99

Previous Close

$6.38

Open

$6.37

Volume

14,087

Day Range

$6.07 - $6.64

Enterprise Value

84.44M

Cash

9.785M

Avg Qtr Burn

N/A

Insider Ownership

25.95%

Institutional Own.

49.49%

Qtr Updated

04/30/25


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date